• Certified Lab Equipment & Reagents
  • Fast Dispatch on In-Stock Items
  • Expert Scientific Support

Product details

RET Proto-oncogene (RET/2662), 0.2mg/mL

Catalog number BNUB2662-500

Price for BNUB2662-500

Sign In for Pricing

Size / count 1x 500 µL

About this product

The Ret proto-oncogene is structurally related to the growing family of tyrosine kinase transmembrane receptors and is involved in GDNF signaling. RET expression is reported in several regions of the central nervous system; in the developing cranial nerve ganglia and a subset of cells within dorsal root ganglia, in motor neurons in the spinal cord and hindbrain, in neuro-retina and the growing tips of the renal collecting ducts in developing kidney. Alterations in RETgene are associated with diseases including papillary thyroid carcinoma, multiple endocrine neoplasia (type 2A and 2B), familial medullary thyroid carcinoma, and a congenital developmental disorder known as Hirschsprung's disease. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

Specifications

Catalog number
BNUB2662-500
Size / count
1x 500 µL
Dry ice
No
Hazardous
No
Discontinued
No
CAS Number
9007-83-4
Synonyms
Cadherin family member 12 (CDHF12) ; Cadherin related family member 16 (CDHR16) ; ELKS; HSCR1; Hydroxyaryl protein kinase; MEN2A; MEN2B; MTC1; Multiple endocrine neoplasia and medullary thyroid carcinoma 1; Oncogene RET; Proto-oncogene c-Ret; Proto-oncogene tyrosine-protein kinase receptor ret; PTC; RET; RET ELE1; RET51; RET9
UNSPSC
41116161
UNSPSC Description
Primary and secondary antibodies for multiple methodology immunostaining detection application
Gene Name
RET
Gene ID
5979
NCBI Gene ID
350321
UniProt
P07949
Swiss Prot
P07949
Host
Mouse
Species Reactivity
Human
Reactivity
RET Proto-oncogene
Immunogen
Recombinant fragment (around aa 702-848) of human RET protein (exact sequence is proprietary)
Target Antigen
RET Proto-oncogene
Clonality
Monoclonal
Clone
RET/2662
Type
Primary
Source
Animal
Origin
Animal
Positive Control
Breast, Prostate or Colon Carcinoma.
Stability
2 years
Concentration
0.2 mg/mL
Buffer
PBS, 0.05% BSA, 0.05% azide
Molecular Weight
150 kDa (precursor) ; 170 kDa (Mature)
Shipping Conditions
RT (ND)
Storage Conditions
Stable at room temperature or 37°C (98°F) for 7 days.
Shelf Life
Guaranteed for at least 24 months from date of receipt when stored as recommended
Fragment
IgG2b, kappa
Species
Mus musculus (mouse), BSA from bovine serum (Bos taurus) or recombinant BSA produced in Chinese hamster ovary cells.
Classification
PBS, 0.05% BSA, 0.05% sodium azide (CAS 26628-22-8)
Conjugate
Purified, with BSA

Frequently Asked Questions

What is the catalog number for RET Proto-oncogene (RET/2662), 0.2mg/mL?

The catalog number for RET Proto-oncogene (RET/2662), 0.2mg/mL is BNUB2662-500.

What sizes are available for RET Proto-oncogene (RET/2662), 0.2mg/mL?

RET Proto-oncogene (RET/2662), 0.2mg/mL is available in the following size(s): 1x 500 µL.

Is RET Proto-oncogene (RET/2662), 0.2mg/mL in stock?

RET Proto-oncogene (RET/2662), 0.2mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures RET Proto-oncogene (RET/2662), 0.2mg/mL?

RET Proto-oncogene (RET/2662), 0.2mg/mL is manufactured by Biotium.

What is the estimated delivery time for RET Proto-oncogene (RET/2662), 0.2mg/mL?

Estimated delivery time for RET Proto-oncogene (RET/2662), 0.2mg/mL is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for RET Proto-oncogene (RET/2662), 0.2mg/mL?

The safety data sheet for RET Proto-oncogene (RET/2662), 0.2mg/mL is available here: https://cdn.gentaur.com/products/37/68dd029d061270361e1026e4/msds/bnub2662-500.pdf.

What is RET Proto-oncogene (RET/2662), 0.2mg/mL used for?

The Ret proto-oncogene is structurally related to the growing family of tyrosine kinase transmembrane receptors and is involved in GDNF signaling. RET expression is reported in several regions of the central nervous system; in the developing cranial nerve ganglia and a subset of cells within dorsal

Can this product be used for diagnostic or therapeutic purposes?

No. This product, like all items we supply, is intended for research laboratory use only and must not be used for diagnostics, therapeutics, treatment, or consumption by humans or animals.

What is the shelf life of this product?

Shelf life and expiration dates vary by product and are shown on the product listing and label. Products used beyond their expiration date are not eligible for performance-related returns or refunds, so please check the lot number and expiry before use.

What expression system was used for this recombinant protein?

The expression system, such as E. coli, HEK293, or insect cells, is listed on the datasheet under production details, which can affect post-translational modifications relevant to your application.

You Might Also Like
CD4 (EDU-2), CF405S conjugate, 0.1mg/mL
CD4 (EDU-2), CF405S conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC040345-100
CD3e (CRIS-7), CF640R conjugate, 0.1mg/mL
CD3e (CRIS-7), CF640R conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC401050-500
CD63 (MX-49.129.5), CF405S conjugate, 0.1mg/mL
CD63 (MX-49.129.5), CF405S conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC040525-500
CD54 / ICAM-1 (15.2), CF568 conjugate, 0.1mg/mL
CD54 / ICAM-1 (15.2), CF568 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC682853-500
HLA-Aw32 & HLA-A25 (MHC I) (CATA-1), CF647 conjugate, 0.1mg/mL
HLA-Aw32 & HLA-A25 (MHC I) (CATA-1), CF647 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC471073-100
TGF-beta (1D11.16.8), CF568 conjugate, 0.1mg/mL
TGF-beta (1D11.16.8), CF568 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC680977-100
CD3e (B-B12), CF647 conjugate, 0.1mg/mL
CD3e (B-B12), CF647 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC471052-500
CD106 / VCAM1 (B-K9), CF594 conjugate, 0.1mg/mL
CD106 / VCAM1 (B-K9), CF594 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC940304-100